Compass Oncology

Portland, Oregon 97227

0 studies enrolling now · 3 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion, Metastatic Castration-resistant Prostate Neoplasms, Solid Tumors

Studies at this site

• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors — Completed
• Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion — Stopped early